Healthcare -
Biotechnology - NASDAQ - US
$ 2.12
10.4 %
$ 147 M
Market Cap
-0.68
P/E
IKT - OTHER FINANCING ACTIVITIES
Other Financing Activities IKT - Inhibikase Therapeutics, Inc.
-139 K
LAST VALUE
-1182.15%
2 YEAR CAGR
38.65%
5 YEAR CAGR
0.00%
10 YEAR CAGR